The Enterprise Value as of December 2025 (TTM) for Corvus Pharmaceuticals, Inc. (CRVS) is 655.78M

According to Corvus Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 655.78M. This represents a change of 76.09% compared to the average of 372.42M of the last 4 quarters.

Corvus Pharmaceuticals, Inc. (CRVS) Historical Enterprise Value (quarterly & annually)

How has CRVS Enterprise Value performed in the past?

The mean historical Enterprise Value of Corvus Pharmaceuticals, Inc. over the last ten years is 119.14M. The current 655.78M Enterprise Value has changed 54.94% with respect to the historical average. Over the past ten years (40 quarters), CRVS's Enterprise Value was at its highest in in the September 2025 quarter at 608.65M. The Enterprise Value was at its lowest in in the December 2018 quarter at -7260510.00.

Corvus Pharmaceuticals, Inc. (CRVS) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Corvus Pharmaceuticals, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Corvus Pharmaceuticals, Inc. (CRVS) Average Enterprise Value

How has CRVS Enterprise Value performed in the past?

The current Enterprise Value of Corvus Pharmaceuticals, Inc. (CRVS) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Corvus Pharmaceuticals, Inc. (CRVS) Enterprise Value vs. Peers

How is CRVS’s Enterprise Value compared to its peers?

Corvus Pharmaceuticals, Inc.’s Enterprise Value is less than Olema Pharmaceuticals, Inc. (1.86B), greater than Ventyx Biosciences, Inc. (548.92M), greater than Prothena Corporation plc (278.98M), less than REGENXBIO Inc. (674.74M), greater than Akebia Therapeutics, Inc. (468.78M), greater than Verastem, Inc. (562.10M), less than Gossamer Bio, Inc. (930.39M), less than KalVista Pharmaceuticals, Inc. (710.80M), greater than Absci Corporation (530.11M), less than Compass Therapeutics, Inc. (719.89M),

Build a custom stock screener for Corvus Pharmaceuticals, Inc. (CRVS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Corvus Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Corvus Pharmaceuticals, Inc. (CRVS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Corvus Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.